Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Viridian Therapeutics, Inc. company logo
Viridian Therapeutics, Inc. logo

Viridian Therapeutics, Inc. (VRDN)

Profile

Company profile for Viridian Therapeutics, Inc. (VRDN)
MetricValue
Full NameViridian Therapeutics, Inc.
TickerNASDAQ: VRDN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CountryUnited States
IPO
IndexesNot included
Websiteviridiantherapeutics.com
Employees143

Key Metrics

Viridian Therapeutics, Inc. Key Details
MetricDateValue
Price$30.72
Price, 1D Change+1.72%
Market Cap$3B
-
PE Ratio-
Beta0.91
Revenue$302K
Revenue, 1Y Change-3.82%
EPS-$3.07
EPS, 1Y Change+42.16%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Viridian Therapeutics, Inc. chart

Events

Viridian Therapeutics, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last Split1:15
Next SplitN/AN/A
Last Ticker ChangeMGEN
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

VRDN Estimates
MetricDateValue
EPS-$3.07
EPS Estimate-$3.51
EPS Est. Change-14.17%
Revenue$302.00K
Revenue Estimate$87.69M
Revenue Est. Change+28,936.86%
Current Price$30.72
Price Target-$42.00
Price Tgt. Change-+36.72%

🔒 Log In To Unlock Full Data

EPS

VRDN EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
-$4.94-$5.31-7.53%
-$3.99-$3.07+22.96%
-$3.51N/A-14.17%
-$3.55N/A-15.40%
VRDN EPS reported versus estimate values chart

Revenue

VRDN revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$380.00K$314.00K-17.37%
$314.57K$302.00K-4.00%
$87.69MN/A+28,936.86%
$87.15MN/A+28,756.22%
VRDN revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

VRDN Performance
MetricDateValue
Price, 1Y+53.06%
Price, 3Y+11.87%
Market Cap, 1Y+80.37%
Market Cap, 3Y+158.49%
Revenue, 1Y-3.82%
Revenue, 3Y-89.81%
EPS, 1Y+42.16%
EPS, 3Y+53.89%

🔒 Log In To Unlock Full Data

Technical Indicators

VRDN Technical Indicators
MetricDateValue
Current Price$30.72
SMA 200$19.72
SMA 200 vs Price-35.79%
SMA 50$29.46
SMA 50 vs Price-4.10%
Beta0.91
ATR$1.13
14-Day RSI48.07
10-Day Volatility21.13%
1-Year Volatility52.82%

Dividends

VRDN Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

VRDN Income & Profitability
MetricDateValue
Revenue$302.00K
EPS-$3.07
Gross Profit-$938.00K
Gross Margin-310.60%
Operating Profit-$299.04M
Operating Margin-99.02%
Net Income-$208.56M
Net Margin-89.39%
EBITDA-$266.36M

🔒 Log In To Unlock Full Data

Financial Health

VRDN Financial Health
MetricDateValue
Debt To Equity0.03
Current Ratio15.43
Quick Ratio15.43
Interest Coverage-87.62
F-Score2
Altman Z-Score22.91

Valuations

VRDN Valuations
MetricDateValue
PE Ratio-
PS Ratio41.42
PB Ratio9.33
EV/EBITDA-7.54
Enterprise ValueN/A-

Balance Sheet

VRDN Balance Sheet
MetricDateValue
Book Value$482.75M
Cash & Equivalents$99.59M
Total Assets$742.40M
Current Assets$738.46M
Total Liabilities$70.76M
Current Liabilities$47.87M
Total Debt$23.10M
Short Term Debt$513.00K
Accounts Payable$2.14M

Expenses

VRDN Expenses
MetricDateValue
Total Expenses$299.34M
Operating Expenses$299.34M
Cost Of Goods Sold$1.24M
SG&A$61.08M
D&A$540.00K
Interest Expense$3.05M
Income Tax$0.00

Cash Flow

VRDN Cash Flow
MetricDateValue
CFO-$232.32M
CFI-$228.65M
CFF$457.74M
Capex$511.00K
Free Cash Flow-$232.83M

Recent analyst updates

VRDN Recent analyst updates
MetricDateValue
Needham→
Wedbush→
William Blair
Truist Securities
RBC Capital→
BTIG→
Oppenheimer→
Wells Fargo→
RBC Capital→
Oppenheimer→

Analyst sentiment

Sentiment over the past month
VRDN analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
VRDN institutional ownership distribution chart

Screeners with VRDN

Data Sources & References

  1. VRDN Official Website www.viridiantherapeutics.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1590750/000159075025000020/0001590750-25-000020-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1590750/000159075025000004/0001590750-25-000004-index.htm
  4. VRDN Profile on Yahoo Finance finance.yahoo.com/quote/VRDN
  5. VRDN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vrdn

FAQ

  • What is the ticker symbol for Viridian Therapeutics, Inc.?

    The ticker symbol for Viridian Therapeutics, Inc. is NASDAQ:VRDN

  • Does Viridian Therapeutics, Inc. pay dividends?

    No, Viridian Therapeutics, Inc. does not pay dividends

  • What sector is Viridian Therapeutics, Inc. in?

    Viridian Therapeutics, Inc. is in the Healthcare sector

  • What industry is Viridian Therapeutics, Inc. in?

    Viridian Therapeutics, Inc. is in the Biotechnology industry

  • What country is Viridian Therapeutics, Inc. based in?

    Viridian Therapeutics, Inc. is headquartered in United States

  • When did Viridian Therapeutics, Inc. go public?

    Viridian Therapeutics, Inc. initial public offering (IPO) was on June 18, 2014

  • Is Viridian Therapeutics, Inc. in the S&P 500?

    No, Viridian Therapeutics, Inc. is not included in the S&P 500 index

  • Is Viridian Therapeutics, Inc. in the NASDAQ 100?

    No, Viridian Therapeutics, Inc. is not included in the NASDAQ 100 index

  • Is Viridian Therapeutics, Inc. in the Dow Jones?

    No, Viridian Therapeutics, Inc. is not included in the Dow Jones index

  • When was Viridian Therapeutics, Inc. last earnings report?

    Viridian Therapeutics, Inc.'s most recent earnings report was on November 5, 2025

  • When does Viridian Therapeutics, Inc. report earnings?

    The next expected earnings date for Viridian Therapeutics, Inc. is February 26, 2026